Shareholders meeting

Ref: AHCL/2026-27/C021 July 02, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 Scrip Code – 544350 Symbol : AGARWALEYE Dear Sir / Madam, Sub: Proceedings of the Hon'ble National Company Law Tribunal (“NCLT”) Convened Meeting of the Equity Shareholders of Dr. Agarwal's Health Care Limited in relation to the Scheme of Amalgamation of Dr. Agarwal's Eye Hospital Limited with Dr. Agarwal's Health Care Limited and their respective shareholders and creditors ("Scheme") Ref: Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Further to the captioned subject, reference and our earlier letters dated June 01, 2026, in relation to the subject mentioned Scheme, we enclose herewith a Summary of Proceedings of the Hon'ble NCLT Convened Meeting of the Equity Shareholders of Dr. Agarwal's Health Care Limited (“the Company”), held on Thursday, July 02, 2026, at 12:30 P.M. (IST), at The Music Academy, T.T.K. Road, Chennai – 600 014. The Resolutions, as set out in the Notice of the Meeting dated June 01, 2026, in relation to the Scheme, have been duly transacted by the Equity Shareholders of the Company. This information is also hosted on the Company’s website at: https://dragarwals.co.in/dr-agarwals- health-care/#corporate-announcement. We request you to kindly take the above on record. For Dr. Agarwal’s Health Care Limited Thanikainathan Arumugam Company Secretary and Compliance Officer Encl.: as above SUMMARY OF PROCEEDINGS OF THE HON'BLE NATIONAL COMPANY LAW TRIBUNAL CONVENED MEETING OF THE EQUITY SHAREHOLDERS OF DR. AGARWAL'S HEALTH CARE LIMITED, PURSUANT TO THE ORDER OF THE HON'BLE NCLT, CHENNAI BENCH, DATED MAY 05, 2026 Pursuant to the Order dated May 05, 2026, passed by the Hon'ble National Company Law Tribunal, Chennai Bench ("NCLT"), in Company Application No. CA(CAA)/19/CHE/2026, the Meeting of the Equity Shareholders of Dr. Agarwal's Health Care Limited was held on Thursday, July 02, 2026 at 12:30 P.M. (IST) at The Music Academy, T.T.K. Road, Chennai – 600 014. As directed by the Hon'ble NCLT, Shri L N Gupta, duly appointed Chairperson, chaired the proceedings of the Meeting. Mr. Thanikainathan Arumugam, Company Secretary and Compliance Officer of the Company, welcomed the equity shareholders to the Meeting and invited Shri L N Gupta, Chairperson, to formally commence the proceedings of the Meeting. The total number of shareholders of the Company as on the record date, i.e., Wednesday, June 03, 2026, was 43,122. The details of shareholders present / in attendance at the venue of the Meeting are as follows: Promoters and Category Public Total Promoter Group No. of Shareholders present in the meeting 17 30 47 either in person or through proxy The Chairperson called the Meeting to order as the requisite quorum of 30 equity shareholders (as prescribed by the Hon'ble NCLT) was present at the meeting The Chairperson took note that the Register of Members, Proxy Register, certified copy of the NCLT Order dated May 05, 2026, the Notice dated June 01, 2026, along with the Scheme, Explanatory Statement under Sections 102, 230 and 232 of the Companies Act, 2013 and other annexures, were available for inspection at the Meeting and had informed the equity shareholders that the following Resolution was proposed to be passed at the Meeting: Sr. Type of Particulars No. Resolution To consider and approve the Scheme of Amalgamation of Dr. Agarwal's Eye Hospital Limited (Transferor Company) with Dr. Agarwal's Health 1. Special Majority* Care Limited (Transferee Company) and their respective shareholders and creditors, under Sections 230 to 232 of the Companies Act, 2013. *As prescribed under section 230(6) of the Companies Act, 2013 read with the SEBI Master Circular on Scheme of Arrangement dated June 20, 2023. The shareholders were informed that the detailed Explanatory Statement setting out material information with respect to the Resolution, including the rationale for the Scheme, formed part of the Notice of the Meeting. With the permission of the shareholders, the Notice of the Meeting along with the Explanatory Statement, the Scheme of Amalgamation and other accompanying documents were taken as read. It was also brought to the attention of the Members that since the Notice had already been dispatched to all shareholders on June 01, 2026, and the Resolution had been put to vote through remote e-voting, the Resolution was not required to be proposed and seconded. On the invitation of the Chairperson, Members who had registered themselves as speakers addressed the Meeting and sought clarifications on the Scheme of Amalgamation. The representatives of the Company responded to the queries of the shareholders and provided necessary clarifications. Thereafter, the Chairperson announced that voting would be conducted through e-voting (at venue) and by means of polling paper (for valid proxy holders) and that the remote e-voting facility shall be kept open during the course of the meeting. The Chairperson requested Shri Shivam Parashar, Scrutinizer, to oversee the orderly conduct of the voting process. Shri Shivam Parashar explained the voting procedure to the equity shareholders and proxy holders present at the Meeting. Members / their authorized representatives who had not availed the remote e-voting facility cast their votes through the e-voting facility made available at the venue. Proxy holders present at the Meeting cast their votes by means of depositing their polling papers in the polling box. The voting was declared closed by the Chairperson, and the Scrutinizer was requested to take custody of the polling box, consolidate the results of the venue e-voting, polling papers with the remote e- voting results and to submit his Consolidated Report. The Meeting concluded at 01:15 P.M. (IST). For Dr. Agarwal’s Health Care Limited Thanikainathan Arumugam Company Secretary and Compliance Officer